Featured Posts
Galatea Bio and Fabric Genomics, a GeneDx company, announced a strategic collaboration to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to...Read More
RNA Research for All: How Advances in Total RNA Sequencing are Transforming Accessibility The study of the transcriptome has revolutionized our understanding of gene expression and regulation across biological systems....Read More
Roche announced today a strategic collaboration with Broad Clinical Labs to develop and pilot groundbreaking applications using Roche’s recently unveiled next-generation sequencing (NGS) Sequencing By Expansion (SBX) technology. This collaboration...Read More
We are pleased to announce that Count Me In (CMI), a groundbreaking research initiative dedicated to advancing biomedical research through direct patient engagement, has joined forces with Broad Clinical...Read More
The goal of developing a 5 billion single-cell atlas within the next three years took a big step forward with the recent announcement of a new effort between longstanding partners...Read More
Broad Clinical Labs is proud to support a collaborative effort between Illumina and Broad Institute’s Spatial Technology Platform (STP) by providing sequencing services for the recently announced Spatial Flagship Project...Read More
We are excited to announce that Dr. Victoria Popic and her lab have joined BCL to drive research and development efforts at the intersection of AI and clinical genomics. As...Read More
In the pursuit of cost-effective genomics testing, researchers and clinicians face a challenging trade-off. While whole genome sequencing (WGS) provides comprehensive genetic insights, its high cost remains a significant barrier,...Read More
Whole genome sequencing (WGS) is a powerful platform for discovery, screening, and diagnosis. Our human genome sequencing process builds on almost 30 years of institutional expertise dating back to the...Read More
Galatea Bio and Fabric Genomics, a GeneDx company, announced a strategic collaboration to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to...
RNA Research for All: How Advances in Total RNA Sequencing are Transforming Accessibility The study of the transcriptome has revolutionized our understanding of gene expression and regulation across biological...
Roche announced today a strategic collaboration with Broad Clinical Labs to develop and pilot groundbreaking applications using Roche’s recently unveiled next-generation sequencing (NGS) Sequencing By Expansion (SBX) technology. This...
Authors: Diane Diehl, Niall Lennon
We are pleased to announce that Count Me In (CMI), a groundbreaking research initiative dedicated to advancing biomedical research through direct patient engagement, has joined forces with Broad...
The goal of developing a 5 billion single-cell atlas within the next three years took a big step forward with the recent announcement of a new effort between longstanding...
Broad Clinical Labs is proud to support a collaborative effort between Illumina and Broad Institute’s Spatial Technology Platform (STP) by providing sequencing services for the recently announced Spatial Flagship...
